Natalie Rabinovich-Maimon
Kfar Saba, M 44180, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Impact of Angiotensin-Converting Enzyme Inhibitors (ACEIs) on the Efficacy of Immunotherapy in Metastatic NSCLC.
Journal: Medical sciences (Basel, Switzerland)
Published: June 26, 2026
Impact of EGFR variant allele frequency on treatment-related adverse events in patients with metastatic NSCLC treated with osimertinib.
Journal: Frontiers in molecular biosciences
Published: May 11, 2026
Variant allele frequency as a predictor of treatment response to osimertinib in EGFR-mutated NSCLC.
Journal: Frontiers in molecular biosciences
Published: March 03, 2026
Impact of Statin Use on Immunotherapy Outcomes and Efficacy in Non-Small Cell Lung Cancer Patients.
Journal: International journal of molecular sciences
Published: January 07, 2026
Exploring the Impact of TP53 Mutation and Wild-Type Status on the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer.
Journal: International journal of molecular sciences
Published: June 07, 2025
Non-Small-Cell Lung Cancer Patients Harboring ROS1 Rearrangement: Real World Testing Practices, Characteristics and Treatment Patterns (ROS1REAL Study).
Journal: Current oncology (Toronto, Ont.)
Published: July 03, 2024
Long term follow-up of EGFR mutated NSCLC cases.
Journal: Translational oncology
Published: July 31, 2020
Efficacy and Safety of ALK Tyrosine Kinase Inhibitors in Elderly Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer: Findings from the Real-Life Cohort.
Journal: Oncology research and treatment
Published: December 28, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026